Answer
If a serious hypersensitivity reaction occurs, tildrakizumab administration should be discontinued immediately and appropriate therapy initiated.
Sources for this answer
- Ilumetri 100 mg solution for injection in pre-filled syringeAlmirall Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked